Combining MHC tetramer and intracellular cytokine staining for CD8+ T cells to reveal antigenic epitopes naturally presented on tumor cells

Journal of Immunological Methods

Volumn 340, Issue 1, 2009, Pages 90-94

  Dimopoulos, Nektaria ^a   Jackson, Heather M ^a   Ebert, Lisa ^a   Guillaume, Philippe ^b   Luescher, Immanuel F ^b   Ritter, Gerd ^a   Chen, Weisan ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Switzerland)

Author keywords

Intracellular cytokine staining; MHC Tetramer; Natural presentation; Tumor antigenic epitope

Indexed keywords

CYTOKINE; EPITOPE; GAMMA INTERFERON; TETRAMER;

ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELL CLONING; CELL CULTURE; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; METHODOLOGY; PRIORITY JOURNAL; STAINING; TUMOR CELL;

ANTIGENS, NEOPLASM; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CYTOKINES; EPITOPES, T-LYMPHOCYTE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS; HUMANS; MELANOMA;

EID: 57249089009     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2008.09.023     Document Type: Article

References (10)

1. Altman J.D., Moss P.A., Goulder P.J., Barouch D.H., McHeyzer-Williams M.G., Bell J.I., McMichael A.J., and Davis M.M. Phenotypic analysis of antigen-specific T lymphocytes. Science 274 (1996) 94
2. Clark C.E., and Vonderheide R.H. Getting to the surface: a link between tumor antigen discovery and natural presentation of peptide-MHC complexes. Clin. Cancer Res. 11 (2005) 5333
3. Echchakir H., Mami-Chouaib F., Vergnon I., Baurain J.F., Karanikas V., Chouaib S., and Coulie P.G. A point mutation in the alpha-actinin-4 gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human lung carcinoma. Cancer Res. 61 (2001) 4078
4. Jackson, H., Dimopoulos, N., Mifsud, N., Tai, T., Chen, Q., Svobodova, S., Browning, J., Luescher, I., Stockert, L., Old, L., Davis, I., Cebon, J., Chen, W., 2006. Striking immunodominance hierarchy of naturally-occurring CD8+ and CD4+ T cell responses to tumor antigen NY-ESO-1. J. Immunol. 176, 5908.
5. Jung T., Schauer U., Heusser C., Neumann C., and Rieger C. Detection of intracellular cytokines by flow cytometry. J. Immunol. Methods 159 (1993) 197
6. Kroger C.J., and Alexander-Miller M.A. Cutting edge: CD8+ T cell clones possess the potential to differentiate into both high- and low-avidity effector cells. J. Immunol. 179 (2007) 748
7. Liu H., Rhodes M., Wiest D.L., and Vignali D.A. On the dynamics of TCR: CD3 complex cell surface expression and downmodulation. Immunity 13 (2000) 665
8. Matsueda S., Takedatsu H., Yao A., Tanaka M., Noguchi M., Itoh K., and Harada M. Identification of peptide vaccine candidates for prostate cancer patients with HLA-A3 supertype alleles. Clin. Cancer Res. 11 (2005) 6933
9. Schnurr M., Chen Q., Shin A., Chen W., Toy T., Jenderek C., Green S., Miloradovic L., Drane D., Davis I.D., Villadangos J., Shortman K., Maraskovsky E., and Cebon J. Tumor antigen processing and presentation depends critically on dendritic cell type and the mode of antigen delivery. Blood 105 (2004) 2465
10. Zippelius A., Pittet M.J., Batard P., Rufer N., de Smedt M., Guillaume P., Ellefsen K., Valmori D., Lienard D., Plum J., MacDonald H.R., Speiser D.E., Cerottini J.C., and Romero P. Thymic selection generates a large T cell pool recognizing a self- peptide in humans. J. Exp. Med. 195 (2002) 485